RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • Effects of Par2-Antagonist on Inflammatory Signals and Tight Junction Expression in Protease Activated Canine Primary Epithelial Keratinocytes

        ( Ha-jung Kim ),( Se Kyoo Jeong ),( Soo-jong Hong ),( Kim Ahrens ),( Rosanna Marsella ) 한국피부장벽학회 2016 한국피부장벽학회지 Vol.18 No.2

        Atopic dermatitis (AD) is a common allergic eczematous skin disorder in humans, the incidence of which is increasing worldwide. Protease activated receptor 2 (PAR2) is a mediator of innate immunity expressed on keratinocytes that can induce Th2-related inflammation in AD. Using a validated canine model of spontaneously occurring AD, we previously assessed the expression of PAR2 and thymic stromal lymphopoietin (TSLP) and reported that the expression pattern of skin biopsy samples differed in normal and atopic dogs. Pilot studies in our canine atopic model have also shown decrease tight junction protein expression such as and Zonula Occludens-1 (ZO-1). This study investigated whether PAR2 mediates the expression of TSLP and ZO-1 in canine primary epithelial keratinocytes (CPEKs) by assessing the effects of a PAR2-antagonist (PAR2-ant) on PAR2, TSLP, and ZO-1 immunofluorescence. CPEKs were cultured with serine protease over time with or without PAR2-antagonist and the expressions were quantitated by real-time PCR and fluorescence intensity in CPEKs. Protease significantly increased the expressions of PAR2 and TSLP, but decreased the expression of ZO-1 at each specific incubation time. PAR2-antagonist blocked those effects on each mediator and tight junction. Therefore, blockage of PAR2 can suppress the trypsin-activated initiation of inflammatory signals and the disturbance of tight junction protein CPEK.

      • Effects of PAR2-Antagonist on Inflammatory Signals and Tight Junction Expression in Protease Activated Canine Primary Epithelial Keratinocytes

        김하정 ( Ha-jung Kim ),( Se Kyoo Jeong ),( Soo-jong Hong ),( Ahrens Kim ),( Rosanna Marsella ) 한국피부장벽학회 2016 한국피부장벽학회지 Vol.18 No.2

        Atopic dermatitis (AD) is a common allergic eczematous skin disorder in humans, the incidence of which is increasing worldwide. Protease activated receptor 2 (PAR2) is a mediator of innate immunity expressed on keratinocytes that can induce Th2-related inflammation in AD. Using a validated canine model of spontaneously occurring AD, we previously assessed the expression of PAR2 and thymic stromal lymphopoietin (TSLP) and reported that the expression pattern of skin biopsy samples differed in normal and atopic dogs. Pilot studies in our canine atopic model have also shown decrease tight junction protein expression such as and Zonula Occludens-1 (ZO-1) This study investigated whether PAR2 mediates the expression of TSLP and ZO-1 in canine primary epithelial keratinocytes (CPEKs) by assessing the effects of a PAR2-antagonist (PAR2-ant) on PAR2, TSLP, and ZO-1 immunofluorescence. CPEKs were cultured with serine protease over time with or without PAR2-antagonist and the expressions were quantitated by real-time PCR and fluorescence intensity in CPEKs. Protease significantly increased the expressions of PAR2 and TSLP, but decreased the expression of ZO-1 at each specific incubation time. PAR2-antagonist blocked those effects on each mediator and tight junction. Therefore, blockage of PAR2 can suppress the trypsin-activated initiation of inflammatory signals and the disturbance of tight junction protein CPEK.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼